echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Urinary System > [Phase 2] Standardized Diagnosis and Treatment Courses for Prostate Cancer——Strategies of Endocrine Therapy for Prostate Cancer

    [Phase 2] Standardized Diagnosis and Treatment Courses for Prostate Cancer——Strategies of Endocrine Therapy for Prostate Cancer

    • Last Update: 2021-03-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Explore the new world---standardized curriculum "Prostate Cancer Standardized Diagnosis and Treatment College" project is sponsored by the Beijing Medical Award Foundation, guided by the Chinese Anti-Cancer Association Urology and Andrology Reproductive Tumor Committee, and Yimaitong fully supports it.

    Among them, the "Prostate Cancer Standardized Diagnosis and Treatment Course" aims to promote and promote the knowledge of standardized diagnosis and treatment of prostate cancer, and improve the academic level and professional skills in the field of prostate cancer across the country.

    The second phase of "Prostate Cancer Standardized Diagnosis and Treatment Course" The second phase is "Strategies for Endocrine Therapy of Prostate Cancer" brought by Professor Dai Bo from Fudan University Affiliated Cancer Hospital: Click to watch the highlights video! Highlights Video Endocrine therapy has been used in the field of prostate cancer for many years, covering metastatic castration-sensitive prostate cancer (mHSPC), non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-resistant prostate cancer (mCRPC) ) And many different disease stages.

    In recent years, with the development of new endocrine therapy drugs such as enzalutamide and other related research, the survival benefit of prostate cancer patients has been significantly improved, and the endocrine strategy of prostate cancer has also been greatly changed.

    So, at the stage of mHSPC, nmCRPC and mCRPC, what are the new endocrine therapy drugs? How is the related research progress? This issue of "Strategies for Endocrine Therapy of Prostate Cancer" will discuss and share these topics in detail to help clinicians familiarize and master the progress of endocrine therapy in the field of prostate cancer and better apply new endocrine therapy drugs.

    To watch the full video, please
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.